Premium
Private equity giant Advent International-owned Suven Pharmaceuticals Ltd is scouting for acquisitions in the technology space to bolster its contract development and manufacturing organization (CDMO) platform, a top company executive told VCCircle. The Hyderabad-headquartered company, dealing in pharmaceuticals and fine chemical intermediates, is currently evaluating three to four companies in oligo ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
